Del Mar, CA, United States of America

Lisa Lynn Caralli



 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lisa Lynn Caralli: Innovator in Oncology and Pharmaceuticals

Introduction

Lisa Lynn Caralli is a prominent inventor based in Del Mar, California. She has made significant contributions to the field of medicine and pharmaceuticals, particularly in oncology. With a total of 2 patents, her work focuses on developing innovative treatments for bone lesions caused by malignant neoplasms.

Latest Patents

Caralli's latest patents include a stable dosage form of etidronate-cytarabine conjugate and a pharmaceutical preparation for treating bone lesions caused by malignant neoplasms. The first patent relates to a novel dosage form that ensures the hydrolytic and physical stability of an antitumor preparation. This stable dosage form is a lyophilizate comprising an etidronate-cytarabine conjugate or a pharmaceutically acceptable salt, along with a stabilizer. The stabilizer is a divalent metal salt, which is crucial for maintaining the stability of the conjugate during long-term storage and clinical use. The second patent proposes a medicinal drug that represents a lyophilisate for solution for parenteral administration, aimed at treating bone lesions caused by malignant tumors. This drug allows for intravenous administration, significantly reducing the metabolic activity of bone lesions.

Career Highlights

Lisa Lynn Caralli is associated with Maxwell Biotech Group Ltd., where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing treatment options for patients suffering from severe conditions related to oncology.

Collaborations

Some of her notable coworkers include Ekaterina Alekseevna Ivanova and Alexander Karpeisky, who contribute to her research and development efforts.

Conclusion

Lisa Lynn Caralli's contributions to the field of pharmaceuticals and oncology highlight her dedication to improving patient outcomes through innovative treatments. Her patents reflect a commitment to advancing medical science and providing effective solutions for complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…